Prognostic Biomarkers of Salvage Chemotherapy Following Nivolumab Treatment for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma

Recent studies have suggested the benefit of salvage chemotherapy (SCT) after immune checkpoint inhibitor (ICI) treatment for recurrent and metastatic head and neck squamous cell carcinoma (R/M HNSCC). We retrospectively examined the outcome of SCT and the usefulness of the serum C-reactive protein...

Descripción completa

Detalles Bibliográficos
Autores principales: Wakasaki, Takahiro, Yasumatsu, Ryuji, Masuda, Muneyuki, Takeuchi, Toranoshin, Manako, Tomomi, Matsuo, Mioko, Jiromaru, Rina, Uchi, Ryutaro, Komune, Noritaka, Noda, Teppei, Nakagawa, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463840/
https://www.ncbi.nlm.nih.gov/pubmed/32824226
http://dx.doi.org/10.3390/cancers12082299

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463840/
https://www.ncbi.nlm.nih.gov/pubmed/32824226
http://dx.doi.org/10.3390/cancers12082299

Ejemplares similares